GigXR partners with NUS Medicine to deliver holographic clinical scenarios for Gastroenterology training

28 Mar 2022

NUS-Monash University collaboration produces universal flu vaccine candidate

Researchers from the NUS Medicine and Monash University have successfully leveraged on a novel vaccine platform to prove that a single shot immunisation containing the M2e peptide was able to trigger long-lasting immune responses that could protect effectively against multiple strains of the flu.

23 Mar 2022

NUS Medicine Launches Philip Yeo Professorship in Medicine

NUS Medicine establishes a new professorship in honour of Mr Philip Yeo, one of Singapore’s best-known public service leaders.

18 Mar 2022

Genetic Ancestry Matters in Childhood Leukemia Treatment Success

Researchers from the NUS Yong Loo Lin School of Medicine and St Jude Children's Research Hospital in the USA have shown that it is important to consider race and genetic ancestry in treating acute lymphoblastic leukemia (ALL) in children.

08 Mar 2022

NUS Yong Loo Lin School of Medicine students and researchers develop novel algorithm to assess immunotherapy benefit in stomach cancer patients

A group of students and researchers from Yong Loo Lin School of Medicine created a novel algorithm to identify patients who would not benefit from joint immunotherapy-chemotherapy treatment.

08 Feb 2022

Harvesting baker's yeast for ageing-related therapeutics

Researchers from Singapore and the UK successfully engineer common baker's yeast to produce D-lysergic acid (DLA), an ingredient used in medicine for dementia and Parkinson's Disease.

08 Feb 2022

NUS Medicine cardiovascular research team develops anticoagulant drugs with high anticlotting efficacy and minimal bleeding

A team lead by Research Assistant Professor Koh Cho Yeow from the Cardiovascular Diseases Translational Research Programme at Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Cardiovascular Research Institute, Associate Professor Mark Chan, from the Department of Medicine, NUS Medicine, who is also the Deputy Director (Clinical Research Matters) from the Cardiovascular Research Institute and National University Heart Centre, as well as, Professor R. Manjunatha Kini from the Department of Biological Sciences at NUS, developed a series of thrombin inhibitors to be powerful anticoagulants, commonly known as blood thinners or anticlotting medications.

08 Feb 2022

Medical education goes Holographic with mixed reality from Microsoft

NUS Yong Loo Lin School of Medicine partners with Microsoft to useholographic technology to teach medical and nursing undergraduates

08 Feb 2022

Antibody from recovered COVID-19 patients found to reduce severity of disease

Study found that an antibody, P36-5D2, demonstrated a substantial decrease in infectious virus load in the lungs and brain, and reduced lung disease in laboratory models

13 Jan 2022

Antibody from recovered COVID-19 patients found to reduce severity of disease

Researchers at NUS Medicine and Beijing Tsinghua University found that an antibody, P36-5D2, demonstrated a substantial decrease in infectious virus load in the lungs and brain, and reduced lung disease in laboratory models.

11 Jan 2022

Medical education goes Holographic with mixed reality from Microsoft

NUS Yong Loo Lin School of Medicine partners with Microsoft to use holographic technology to teach medical and nursing undergraduates.